Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%

Liquidia stock crashed Monday after the FDA delayed the final approval for its drug, Yutrepia, for patients with a pair of lung diseases. The post Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38% appeared first on Investor's Business Daily.

Aug 19, 2024 - 11:40
 0  8

Liquidia stock crashed Monday after the FDA delayed the final approval for its drug, Yutrepia, for patients with a pair of lung diseases.

The post Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38% appeared first on Investor's Business Daily.

iShook Opinion "iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.